Amini: This varies quite a bit by stage — operable vs. nonoperable — and patients’ performance status and preference. Additionally, more relevant to medical oncology but equally, if not more, ...
Amini: The systemic landscape is constantly changing and is very exciting. It will only become more complicated for our ...
The five-year survival rate for lung cancer patients increased from 18% eight years ago to 30% in 2025. WakeMed treats 200 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results